A potential role for cannabichromene in modulating TRP channels during acute respiratory distress syndrome

Keyphrases

• Acute Respiratory Distress Syndrome 100%
• TRP Channels 100%
• Cannabichromene 100%
• Transient Receptor Potential Vanilloid 1 (TRPV1) 25%
• Inhalants 25%
• Placebo 16%
• Sham 16%
• Protective Effect 16%
• Inflammatory Diseases 16%
• Lung Tissue 16%
• Therapeutic Modalities 16%
• Poly IC 16%
• Cannabinoids 16%
• Lung 8%
• Inflammatory Cytokines 8%
• Male Mice 8%
• C57BL 8%
• Immunohistochemistry 8%
• Hypoxia 8%
• Health Systems 8%
• Homeostasis 8%
• Statistical Analysis 8%
• Double-stranded RNA 8%
• Quality of Life 8%
• Therapeutic Target 8%
• Putative Drug Targets 8%
• Further Analysis 8%
• Histologic 8%
• Human Subjects 8%
• Post Hoc Test 8%
• Beneficial Effects 8%
• Hospitalization Rate 8%
• Mortality Rate 8%
• Life-threatening 8%
• Murine Model 8%
• Daily Dose 8%
• Once-daily Dosing 8%
• Specific Treatment 8%
• Effective Alternative 8%
• One-way Analysis of Variance 8%
• First Dose 8%
• Alternative Therapy 8%
• Outcome Quality 8%
• Alternative Therapeutics 8%
• Clinical Syndromes 8%
• Transient Receptor Potential Cation Channel 8%
• Pulmonary System 8%
• Systemic Inflammatory Diseases 8%
• Translational Model 8%
• O2 Saturation 8%
• Intranasal Administration 8%
• COVID-19 Pandemic 8%
• Immune Balance 8%
• Flow Cytometry Method 8%
• TRP Cation Channel 8%
• TRPV2 8%
• Inhaler Devices 8%

Pharmacology, Toxicology and Pharmaceutical Science

• Adult Respiratory Distress Syndrome 100%
• Transient Receptor Potential Channel 100%
• Cannabichromene 100%
• Inflammatory Disease 25%
• Mouse 16%
• Symptom 16%
• Placebo 16%
• Cannabinoid 16%
• Polyinosinic Polycytidylic Acid 16%
• Cytokine 8%
• Hypoxia 8%
• C57BL 6 Mouse 8%
• Flow Cytometry 8%
• Mortality Rate 8%
• Syndrome 8%
• Human 8%
• Double Stranded RNA 8%
• Pandemic 8%